Startup behind first FDA-approved prescription software to go public in $1.6B SPAC deal

Prescription software startup Pear Therapeutics on Tuesday became the latest local company to go public through a reverse merger with a special-purpose acquisition company, or SPAC.

Source: bizjournals.com Health Care:Biotechnology headlines - June 22, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news